Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)

v3.21.2
SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) - $ / shares
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Mar. 31, 2021
Net Loss Per Common Share      
Shares excluded from the calculation of weighted average dilutive common shares 5,216,521 1,258,654  
Number of warrants exercisable (in shares) 368,711    
Warrants term (in years) 5 years   5 years
Warrants to purchase shares of common stock 368,711    
Exercise price of warrants (in dollars per share) $ 5.50   $ 5.50
Aggregate of common stock and warrant to purchase   1,555,314  
Common stock issued on conversion of outstanding   1,461,091  
Stock options      
Net Loss Per Common Share      
Shares excluded from the calculation of weighted average dilutive common shares 94,447 97,856  
Warrants      
Net Loss Per Common Share      
Shares excluded from the calculation of weighted average dilutive common shares 5,122,074 1,138,556  
Convertible notes      
Net Loss Per Common Share      
Shares excluded from the calculation of weighted average dilutive common shares 0 22,242